The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer.

Companies expect first commercial kits will be available by year-end. Cygnus Technologies is partnering with Gyros to develop application-specific immunoassay kits optimized to run on the Gyros ...

(RTTNews) - Agilent Technologies Inc. (A) said that it has launched its Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay or ELISA kit that is intended for the qualitative detection of ...

Immunoassays are methods for detecting and quantifying analytes within a biological sample based on specific antigen-antibody reaction. They have been widely used in scientific research and ...

March 25, 2014, Uppsala, Sweden — Gyros AB, a leader in utilization of microfluidic technologies to miniaturize and automate immunoassays, today announced that EMD Millipore, Life Science division of ...

Gamma Therapeutics, Inc., an Oregon early stage biotechnology venture developing cardiovascular disease diagnostic tests, surgical therapy and military medicine solutions, announced today that it has ...

Canopy Biosciences, a Bruker Company, today announced the launch of a first in a series of assay kits for ChipCytometry TM, a quantitative, high dynamic range (HDR) and high-resolution multiplexing ...